shot-button
Maharashtra Elections 2024 Maharashtra Elections 2024
Home > News > World News > Article > COVID 19 Pfizer BioNTech seek vaccine OK for children

COVID-19: Pfizer-BioNTech seek vaccine OK for children

Updated on: 01 May,2021 07:42 AM IST  |  Brussels
Agencies |

Say their submission to the European Medicines Agency was based on an advanced study in more than 2,000 adolescents that showed it to be safe

COVID-19: Pfizer-BioNTech seek vaccine OK for children

Employees work in the production of BioNTech/Pfizer’s Comirnaty vaccine at Allergopharma’s production facilities in Reinbek, Germany. Pic/AP

Pfizer and BioNTech have submitted a request for European Union drug regulators to extend the approval of the companies’ novel Coronavirus vaccine to include children ages 12 to 15, a move that could offer younger and less at-risk populations in Europe access to the shots for the first time.


In a statement on Friday, the two companies said their submission to the European Medicines Agency was based on an advanced study in more than 2,000 adolescents that showed the vaccine to be safe and effective. The children will continue to be monitored for longer-term protection and safety for another two years. BioNTech and Pfizer previously had requested their emergency use authorisation with the US Food and Drug Administration also be extended to children 12-15.


German Health Minister Jens Spahn welcomed the news that the vaccine might soon get the green light for older children. “This can make a further real difference to our vaccine campaign, if approval is granted,” he said on the sidelines of a visit to a vaccine manufacturing  plant in the German town of Reinbek.


US won’t release AstraZeneca

The US Food and Drug Administration will not release AstraZeneca’s coronavirus  vaccine for export to other countries until it is sure the doses have been manufactured to US quality standards and will be safe and effective, a government official told CNN on Thursday. According to CNN, The White House said on Monday it would ship doses of AstraZeneca vaccine to other countries, including India, after a safety review by the FDA. AstraZeneca is yet to apply for emergency use authorisation (EUA) in the US, but it has been making tens of millions of doses in US in expectation it will apply for and receive EUA eventually.

France finds 1st cases of variant sweeping India

France has announced its first confirmed cases of the virus variant that is sweeping over India, just as the French president outlined a national reopening plan after six months of virus restrictions. The Health Ministry announced late Thursday night that three people tested positive for the new variant in the Bouches-du-Rhone and Lot et Garonne regions of southern France. All three had travelled to India, and are under medical observation.

Hong Kong health adviser warns of a fifth COVID-19 wave

A top Hong Kong public health adviser has warned of a potential fifth wave of COVID-19 infections emerging in the next couple of weeks after authorities identified the city’s first untraceable case with a mutant strain and evacuated hundreds from a residential block overnight.

Brazil tops 400,000 virus deaths

Brazil has became the second country to officially top 400,000 COVID-19 deaths, losing another 100,000 lives in just one month, as some health experts warn there may be gruesome days ahead when the Southern Hemisphere enters winter.

6,92,879
No. of new cases reported globally in the past 24 hours

149,910,744
Total no. of cases worldwide

3,155,168
Total no. of deaths worldwide

Source: WHO/Johns Hopkins

This story has been sourced from a third party syndicated feed, agencies. Mid-day accepts no responsibility or liability for its dependability, trustworthiness, reliability and data of the text. Mid-day management/mid-day.com reserves the sole right to alter, delete or remove (without notice) the content in its absolute discretion for any reason whatsoever

"Exciting news! Mid-day is now on WhatsApp Channels Subscribe today by clicking the link and stay updated with the latest news!" Click here!


Mid-Day Web Stories

Mid-Day Web Stories

This website uses cookie or similar technologies, to enhance your browsing experience and provide personalised recommendations. By continuing to use our website, you agree to our Privacy Policy and Cookie Policy. OK